A carregar...
Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide
Genotoxic chemotherapy with temozolomide (TMZ) is a mainstay of treatment for glioblastoma (GBM); however, at best, TMZ provides only modest survival benefit to a subset of patients. Recent insight into the heterogeneous nature of GBM suggests a more personalized approach to treatment may be necessa...
Na minha lista:
Publicado no: | Oncotarget |
---|---|
Main Authors: | , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Impact Journals LLC
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5308652/ https://ncbi.nlm.nih.gov/pubmed/27494880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10973 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|